Business & Industry Focus
Register Now: 10th Annual Nashville Healthcare Fraud Conference | December 12-13The California Insurance Frauds Prevention Act: Recent Developments Regarding California’s Powerful Commercial Health Insurance Fraud StatuteWatch Now | Legal Rx: How to Navigate Controlled Substances Enforcement & Diversion Webinar
Falsity
Fraud and Abuse Chapter of Health Law Handbook, 2024-2025 EditionControlled Substances Act and False Claims Act CollideMedicare Advantage Plan Highlights Distinction for FCA Purposes between Clinically Inaccurate Diagnoses and Clinically Accurate Diagnoses that Allegedly Violate Subregulatory Guidelines
Pharmaceutical Manufacturers
Second Circuit Agrees that the Anti-Kickback Statute Does Not Contain a “Corruption” ElementCourt Decision Upholding OIG’s Rejection of Pharmaceutical Company’s Drug Co-Pay Assistance ProgramThe California Insurance Frauds Prevention Act: What to Know About California’s Powerful Commercial Health Insurance Fraud Statute
Physician Compensation
Register Now | 8th Annual Nashville Healthcare Fraud ConferenceUpdate: Third Circuit Allows Allegations of Improper Compensation under the Stark Law to Proceed, but Reverses Controversial "Varies with Volume or Value" ReasoningThird Circuit Holds Allegations of Improper Compensation Methodologies under the Stark Law Survive Motion to Dismiss